Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Share-based Compensation (2017 - 2025)

Inspire Medical Systems' Share-based Compensation history spans 9 years, with the latest figure at $28.0 million for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 4.03% year-over-year to $28.0 million; the TTM value through Dec 2025 reached $130.3 million, up 12.29%, while the annual FY2025 figure was $130.3 million, 12.29% up from the prior year.
  • Share-based Compensation for Q4 2025 was $28.0 million at Inspire Medical Systems, down from $29.5 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $41.7 million in Q2 2025 and bottomed at $6.0 million in Q1 2021.
  • The 5-year median for Share-based Compensation is $20.7 million (2023), against an average of $20.3 million.
  • The largest annual shift saw Share-based Compensation surged 118.43% in 2021 before it decreased 4.03% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $7.0 million in 2021, then soared by 113.39% to $15.0 million in 2022, then skyrocketed by 52.32% to $22.8 million in 2023, then increased by 27.5% to $29.1 million in 2024, then fell by 4.03% to $28.0 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Share-based Compensation are $28.0 million (Q4 2025), $29.5 million (Q3 2025), and $41.7 million (Q2 2025).